|
CDC5L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.48340000000391E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.409700E-04 |
| Normal-vs-Stage2 |
7.76100000000612E-05 |
| Normal-vs-Stage3 |
2.62070000001113E-06 |
| Normal-vs-Stage4 |
2.52980000003955E-06 |
| Stage1-vs-Stage2 |
1.961160E-01 |
| Stage1-vs-Stage3 |
1.212810E-01 |
| Stage1-vs-Stage4 |
6.540500E-02 |
| Stage2-vs-Stage3 |
8.783400E-01 |
| Stage2-vs-Stage4 |
8.475400E-01 |
| Stage3-vs-Stage4 |
6.979200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.0163000000204E-06 |
| Normal-vs-AfricanAmerican |
1.011350E-01 |
| Normal-vs-Asian |
1.776090E-03 |
| Caucasian-vs-AfricanAmerican |
1.761220E-01 |
| Caucasian-vs-Asian |
7.089600E-01 |
| AfricanAmerican-vs-Asian |
3.585400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.71580000002992E-07 |
| Normal-vs-Female |
4.14440000000571E-05 |
| Male-vs-Female |
2.559000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.225000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.37389999999016E-06 |
| Normal-vs-Age(61-80Yrs) |
1.5581000001319E-07 |
| Normal-vs-Age(81-100Yrs) |
2.685200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.718000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.227910E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.103200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.365400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.816800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.460640E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.465700E-02 |
| Classical-VS-Follicular |
1.6520599999903E-05 |
| Classical-VS-Other |
1.745230E-01 |
| Classical-VS-Normal |
1.115620E-03 |
| Tall-VS-Follicular |
1.985780E-01 |
| Tall-VS-Other |
5.705200E-01 |
| Tall-VS-Normal |
1.790890E-04 |
| Follicular-VS-Other |
9.038400E-01 |
| Follicular-VS-Normal |
3.70739999810965E-08 |
| Other-VS-Normal |
1.044410E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.87780000005367E-07 |
| Normal-vs-N1 |
3.99119999999753E-05 |
| N0-vs-N1 |
8.120800E-01 |
|
|
